These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22360479)

  • 1. Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics.
    Rosenberg HF; Domachowske JB
    Curr Med Chem; 2012; 19(10):1424-31. PubMed ID: 22360479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody Epitopes of Pneumovirus Fusion Proteins.
    Huang J; Diaz D; Mousa JJ
    Front Immunol; 2019; 10():2778. PubMed ID: 31849961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization strategies for the prevention of pneumovirus infections.
    Bennett N; Ellis J; Bonville C; Rosenberg H; Domachowske J
    Expert Rev Vaccines; 2007 Apr; 6(2):169-82. PubMed ID: 17408367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gammaherpesvirus licenses CD8 T cells to protect the host from pneumovirus-induced immunopathologies.
    Dourcy M; Maquet C; Dams L; Gilliaux G; Javaux J; Desmecht D; Mack M; Dewals BG; Machiels B; Gillet L
    Mucosal Immunol; 2020 Sep; 13(5):799-813. PubMed ID: 32424182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies.
    Shang Z; Tan S; Ma D
    Int J Biol Sci; 2021; 17(14):4073-4091. PubMed ID: 34671221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus: prospects for new and emerging therapeutics.
    Jorquera PA; Tripp RA
    Expert Rev Respir Med; 2017 Aug; 11(8):609-615. PubMed ID: 28574729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus.
    Tian P; Wang Y; Liu H; Yang Y; Wu X; Wei H; Chen T
    Front Cell Infect Microbiol; 2019; 9():275. PubMed ID: 31417879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumovirus-Induced Lung Disease in Mice Is Independent of Neutrophil-Driven Inflammation.
    Cortjens B; Lutter R; Boon L; Bem RA; van Woensel JB
    PLoS One; 2016; 11(12):e0168779. PubMed ID: 28005954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention.
    Rosenberg HF; Bonville CA; Easton AJ; Domachowske JB
    Pharmacol Ther; 2005 Jan; 105(1):1-6. PubMed ID: 15626452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host Components Contributing to Respiratory Syncytial Virus Pathogenesis.
    Carvajal JJ; Avellaneda AM; Salazar-Ardiles C; Maya JE; Kalergis AM; Lay MK
    Front Immunol; 2019; 10():2152. PubMed ID: 31572372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection.
    Morris D; Ansar M; Speshock J; Ivanciuc T; Qu Y; Casola A; Garofalo R
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31398832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
    Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
    Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ongoing developments in RSV prophylaxis: a clinician's analysis.
    Rezaee F; Linfield DT; Harford TJ; Piedimonte G
    Curr Opin Virol; 2017 Jun; 24():70-78. PubMed ID: 28500974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection.
    Claassen EA; van der Kant PA; Rychnavska ZS; van Bleek GM; Easton AJ; van der Most RG
    J Immunol; 2005 Nov; 175(10):6597-604. PubMed ID: 16272314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.
    Corti D; Bianchi S; Vanzetta F; Minola A; Perez L; Agatic G; Guarino B; Silacci C; Marcandalli J; Marsland BJ; Piralla A; Percivalle E; Sallusto F; Baldanti F; Lanzavecchia A
    Nature; 2013 Sep; 501(7467):439-43. PubMed ID: 23955151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment.
    Boukhvalova MS; Yim KC; Kuhn KH; Hemming JP; Prince GA; Porter DD; Blanco JC
    J Infect Dis; 2007 Feb; 195(4):511-8. PubMed ID: 17230410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody and Local Cytokine Response to Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults.
    Yu X; Lakerveld AJ; Imholz S; Hendriks M; Ten Brink SCA; Mulder HL; de Haan K; Schepp RM; Luytjes W; de Jong MD; van Beek J; van Kasteren PB
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pneumonia Virus of Mice (PVM) model of acute respiratory infection.
    Dyer KD; Garcia-Crespo KE; Glineur S; Domachowske JB; Rosenberg HF
    Viruses; 2012 Dec; 4(12):3494-510. PubMed ID: 23342367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier.
    Shrestha N; Gall FM; Mathieu C; Hierweger MM; Brügger M; Alves MP; Vesin J; Banfi D; Kalbermatter D; Horvat B; Chambon M; Turcatti G; Fotiadis D; Riedl R; Plattet P
    mBio; 2021 Dec; 12(6):e0262121. PubMed ID: 34724816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.
    Browne SK; Beeler JA; Roberts JN
    Vaccine; 2020 Jan; 38(2):101-106. PubMed ID: 31706809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.